L.E.K. Consulting appoints Borja Sangrador partner in Spain
Global consulting firm L.E.K. Consulting has welcomed a new partner in its Madrid office.
Borja Sangrador joins L.E.K. Consulting – a strategy consultancy with over 2,000 staff worldwide – with two decades of experience, gained in healthcare and management consulting.
A member of the Healthcare & Life Sciences practice, Sangrador specialises in commercial strategies, value creation, transformation, market entry, and transaction due diligence on both the sell and buy sides.
Prior to joining L.E.K. Consuling, Sangrador was Chief Transformation Officer for Donte Group, a private equity-backed dental company, and Chief of Strategy at Cantabria Labs, a leading pharmaceutical company focussed on dermatology.
Sangrador’s life in consulting was spent at PwC in its consulting arm (five years), and later on at Strategy&, where he latterly served as the partner in charge for its Healthcare & Pharma industry vertical in Spain.
His consulting track record includes over 50 engagements and transactions for healthcare institutions and private equity groups, with a focus on healthcare providers, nursing homes, hospital providers, pharmaceuticals, medical devices, dental care, and veterinary care.
“We are particularly pleased to welcome a highly experienced and senior practitioner to augment our Healthcare & Life Sciences team in Europe. We continue to grow our client offering in Europe and Borja’s appointment confirms our Madrid office as a key hub,” commented Ben Faircloth, L.E.K. Consulting’s European leader.
L.E.K. Consulting established its Madrid office in 2021. The hub is led by Jacqueline Thompson and Carmen Morales Garcia, who similar to Sangrador both have a background at PwC and its strategic consulting subsidiary Strategy&.